| abstract |
The invention relates to novel solid pharmaceutical compositions comprising the angiotensin II telmisartan receptor antagonist, a basic agent, a surfactant or emulsifier and a water soluble diluent, for example, in the form of granules or in the form of a powder, as well as solid oral formulations ready to use / ingest, for example, capsule and tablet formulations manufactured from said pharmaceutical compositions, and methods for producing said compositions and formulations using a fluid bed granulation process or a drying process by spray. |